Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care

BACKGROUND: MP-AzeFlu (Dymista®; spray of azelastine/fluticasone propionate) is the most effective allergic rhinitis (AR) treatment available. Its effect on asthma outcomes in patients with AR and asthma is unknown. METHODS: This pre-post historical cohort study, using the Optimum Patient Care Resea...

Descripción completa

Detalles Bibliográficos
Autores principales: De Jong, Hilda J.I., Voorham, Jaco, Scadding, Glenis K., Bachert, Claus, Canonica, Giorgio Walter, Smith, Peter, Wahn, Ulrich, Ryan, Dermot, Castillo, Jose A., Carter, Victoria A., Murray, Ruth B., Price, David B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753940/
https://www.ncbi.nlm.nih.gov/pubmed/33376573
http://dx.doi.org/10.1016/j.waojou.2020.100490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753940/
https://www.ncbi.nlm.nih.gov/pubmed/33376573
http://dx.doi.org/10.1016/j.waojou.2020.100490

Ejemplares similares